omeprazole has been researched along with pirenzepine in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (33.33) | 18.7374 |
| 1990's | 13 (39.39) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Asada, S; Hirata, I; Matsumoto, A; Ohshiba, S; Okumura, Y; Takiuchi, H | 1 |
| Bytzer, P | 1 |
| Bianchi Porro, G; Parente, F | 1 |
| Earnest, DL | 1 |
| Gönne, S; Kromer, W; Postius, S; Riedel, R | 1 |
| De Natale, F; De Natale, G; Marino, A | 1 |
| Debas, HT; Mulholland, MW | 1 |
| Guslandi, M | 1 |
| Bader, JP; Cortot, A; Delchier, JC; Goldfain, D; Isal, JP; Mignon, M; Soule, JC; Travers, B | 1 |
| Dove, PA; German, A; Kuhlman, C; Nielsen, ST | 1 |
| Mahachai, V; Thomson, AB | 1 |
| Fernández, AG; Massingham, R; Roberts, DJ | 1 |
| Grigor'ev, PIa; Isakov, VA; Vasil'eva, ZI | 1 |
| Gönne, S; Kromer, W | 1 |
| Delchier, JC | 1 |
| Dammann, HG; Müller, P; Simon, B; Walter, TA | 1 |
| Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
| Arakawa, Y; Ito, K; Iwasaki, A; Kawamura, Y; Matsuo, Y; Miyazawa, K; Sakai, Y; Tashiro, Y | 1 |
| Busam, J; Garbe, WE | 1 |
| Fukino, Y; Hamada, M; Kajiyama, G; Kamiyasu, T; Sumii, K; Sumii, M; Tari, A | 1 |
| Fukino, Y; Hamada, M; Haruma, K; Inoue, M; Kajiyama, G; Kamiyasu, T; Sumii, K; Sumii, M; Tari, A | 1 |
| Aoki, T; Gang, C; Kashiwagi, H; Omura, K; Omura, N | 1 |
| Bamba, T; Nakajima, S | 1 |
| Arai, H; Inoie, M; Marubuchi, S | 1 |
| Akamatsu, H; Mikawa, K; Nishina, K; Niwa, Y | 1 |
| Kajiyama, G; Kuruhara, Y; Okahara, S; Sumii, K; Tari, A; Yamauchi, R; Yonei, Y | 1 |
| Muravtseva, OV; Vakhrushev, IaM | 1 |
| Evseev, MA; Gostishchev, VK | 1 |
| Serebrova, SIu | 1 |
| Loshchakova, OIu; Vakhrushev, IaM | 1 |
| Evseev, MA; Golovin, RA; Ivakhov, GB | 1 |
8 review(s) available for omeprazole and pirenzepine
| Article | Year |
|---|---|
[Drug therapy of non-ulcer dyspepsia].
Topics: Antacids; Bismuth; Dyspepsia; Histamine H2 Antagonists; Humans; Omeprazole; Pirenzepine; Sucralfate | 1991 |
'Difficult' duodenal ulcer patients: clinical and therapeutic problems.
Topics: Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Pirenzepine; Vagotomy, Proximal Gastric | 1991 |
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Peptic Ulcer; Pirenzepine; Ranitidine; Thiazoles | 1989 |
Drug therapy in peptic ulcer disease.
Topics: Cimetidine; Histamine Antagonists; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Ranitidine | 1989 |
Ulcer-healing drugs and endogenous prostaglandins.
Topics: Aluminum; Animals; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Carbenoxolone; Cimetidine; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Ranitidine; Somatostatin; Stimulation, Chemical; Sucralfate | 1985 |
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
[Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
Topics: Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer; Pirenzepine | 1988 |
[Recent progress in the drug therapy for gastrointestinal bleeding].
Topics: Anti-Ulcer Agents; Cimetidine; Gastric Acidity Determination; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors | 1998 |
3 trial(s) available for omeprazole and pirenzepine
| Article | Year |
|---|---|
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine.
Topics: Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Stomach Ulcer | 1994 |
Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pirenzepine; Radioimmunoassay; Somatostatin; Stomach Ulcer | 1996 |
22 other study(ies) available for omeprazole and pirenzepine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Effects of anti-acid secretory agents on various types of gastric mucus.
Topics: Animals; Anti-Ulcer Agents; Gastric Juice; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Mucus; Omeprazole; Pirenzepine; Prostaglandins E; Ranitidine; Rats | 1992 |
Controlling gastric pH: the impact of newer agents on the critically ill patient.
Topics: Alprostadil; Anti-Ulcer Agents; Critical Care; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Misoprostol; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proglumide; Risk Factors; Somatostatin; Stomach Ulcer; Stress, Physiological | 1990 |
Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Duodenal Ulcer; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Male; Muscarinic Antagonists; Omeprazole; Pantoprazole; Parasympatholytics; Pirenzepine; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulfoxides | 1990 |
Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Cimetidine; Drug Resistance; Drug Therapy, Combination; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pirenzepine; Ranitidine; Zollinger-Ellison Syndrome | 1986 |
Inhibition of [14C]aminopyrine uptake in rat isolated gastric mucosal cells by two classes of psychotropic agents.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aminopyrine; Animals; Benzimidazoles; Bucladesine; Clozapine; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proton-Translocating ATPases; Psychotropic Drugs; Rats; Rats, Inbred Strains | 1987 |
Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Topics: Animals; Benzamides; Cimetidine; Drug Synergism; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Pirenzepine; Pylorus; Ranitidine; Rats; Rats, Inbred Strains | 1988 |
An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastric Acid; Omeprazole; Parasympatholytics; Pirenzepine; Rats; Rats, Inbred Strains; Receptors, Muscarinic | 1988 |
[New antisecretory agents].
Topics: Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Humans; Omeprazole; Pirenzepine; Ranitidine | 1984 |
[Anti-ulcer agents. Clinico-experimental findings].
Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Cimetidine; Histamine Antagonists; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins, Synthetic | 1984 |
[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
Topics: Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Famotidine; Gastrointestinal Hemorrhage; Humans; Magnesium Hydroxide; Omeprazole; Peptic Ulcer Hemorrhage; Pirenzepine; Recurrence; Retrospective Studies; Survival Rate | 1994 |
Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues.
Topics: Actins; Administration, Oral; Animals; Anti-Ulcer Agents; Blotting, Northern; Gastric Acid; Gastrins; Gene Expression Regulation; Injections, Intraperitoneal; Male; Omeprazole; Pirenzepine; Radioimmunoassay; Rats; Rats, Wistar; RNA, Messenger; Somatostatin | 1996 |
Effect of pirenzepine on gastric endocrine cell kinetics during lansoprazole administration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Enterochromaffin Cells; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Kinetics; Lansoprazole; Male; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Rats; Rats, Wistar; Somatostatin; Somatostatin-Secreting Cells | 1998 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Humans; Hydrogen Peroxide; Lansoprazole; Neutrophils; Omeprazole; Phagocytosis; Pirenzepine; Rabeprazole; Superoxides | 2001 |
Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.
Topics: Animals; Anti-Ulcer Agents; Blotting, Northern; Drug Therapy, Combination; Enterochromaffin-like Cells; H(+)-K(+)-Exchanging ATPase; Histamine; Hydrogen-Ion Concentration; Male; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Rats; Rats, Wistar; RNA, Messenger; Stomach | 2001 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Mucins; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Ranitidine; Receptor, Muscarinic M1; Receptors, Muscarinic; Stomach Ulcer | 2002 |
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pirenzepine; Proton Pump Inhibitors | 2005 |
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Muscarinic Antagonists; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Receptors, Histamine H2; Receptors, Muscarinic | 2007 |
[Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biomarkers; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pirenzepine; Ranitidine; Stomach Diseases; Treatment Outcome | 2007 |
[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Topics: Antacids; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Pirenzepine; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2009 |